Strategy Documents

We directly fund and encourage high quality research, education and innovation in MSK health 

Our 2024-27 research strategy places a heavy focus on research projects most capable of delivering benefits to patients and the healthcare system in a relatively short time-span, either by creating new MSK solutions (innovative products and services) or improving clinical practices and processes.

We enable clinicians and scientists to support the millions of people suffering from poor bone, joint and muscle health by:

• Focusing our investments on research projects most capable of delivering benefits to patients and the healthcare system in a relatively short time-span.
• Partnering with leading academic institutions, healthcare organisations, societies, charities (primarily as part of ARMA) and private companies.
• Supporting the overall research eco-system, especially at a time when clinical research faces significant challenges.
• Helping to accelerate the translation of research ideas into new
  products or services.
• Working with others to encourage the development of a more equal, diverse and inclusive research culture, and make the case for increased investment in MSK conditions.

Our strategic plans are informed by the ORUK Board, the Education & Training Advisory Committee and shaped by the work of the Leadership and Management Teams. They aim to strengthen musculoskeletal (MSK) education and training while supporting innovation across the MSK community.

The plans cover three areas of activity:

1. Core training of MSK clinicians (primarily T&O surgeons) to enhance knowledge and skills, career development and improve clinical practice.
2. Thematic events to build ORUK’s profile and reputation within the MSK community.
3. Enhanced training experience for MSK innovators.
4.